MedTrace Logo

Examination of Trends in Colorectal Cancer Patients' Clinical Study Experiences

NCT05891730 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-06-07

No results posted yet for this study

Summary

Clinical study participation percentages haven't always been fully representative of a given demographic.

Participation in this observational clinical research is extremely valuable since it allows people with colorectal cancer to contribute their own experiences and unique viewpoints.

These vital contributions have the potential to affect the development of novel therapies and support services dramatically.

Trial's findings will be critical in furthering the understanding of colorectal cancer, ultimately leading to better patient outcomes.

Conditions

Sponsors & Collaborators

  • Power Life Sciences Inc.

    lead INDUSTRY

Principal Investigators

  • Michael B Gill · Power Life Sciences Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-30
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05891730 on ClinicalTrials.gov